Drug intelligence / Profile preview

apraclonidine

Development stage
Approved
Lead developer
Alcon
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Apraclonidine is a sympathomimetic small molecule used primarily as an ophthalmic solution for the short-term treatment of elevated intraocular pressure in patients with glaucoma who require additional reduction despite maximally tolerated therapy. It is also indicated to prevent or reduce increased intraocular pressure during and after certain types of laser eye surgery. Apraclonidine acts as a relatively selective alpha2-adrenergic receptor agonist, with weaker activity at alpha1 receptors. Its mechanism involves lowering intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow, likely through constriction of afferent ciliary process vessels. Additionally, apraclonidine is used diagnostically in Horner's syndrome due to its unique pharmacological profile.

Brand names
Iopidine
Other names
Apraclonidine Hydrochloride Ophthalmic Solution 0.125%
02

Targets

ADRA1A (α1A)ADRA2A (α2A)ADRA2B (α2B)

Beyond the preview

Go deeper on apraclonidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on apraclonidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call